RIO DE JANEIRO, BRAZIL - After the University of Oxford announced on Saturday that it will resume trials of its Covid-19 vaccine, Fiocruz reasserted its partnership with . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here